Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Colonic Neoplasms 3Rectal Neoplasms 2Neoplasm Metastasis 2Malignant Solid Tumour 1Intestinal Neoplasms 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Digestive System Neoplasms 1

Interventions

Fluorouracil 4Oxaliplatin 3Leucovorin 3Irinotecan 3Bevacizumab 35,10-methylenetetrahydrofolic acid 3Colonoscopy 2Capecitabine 2Bisacodyl 2trametinib 1spartalizumab 1pralsetinib 1nazartinib 1napabucasin 1guadecitabine 1canakinumab 1Ursodeoxycholic Acid 1Tinzaparin 1Suction 1Simvastatin 1Radiotherapy 1Polyethylene Glycols 1Pemetrexed 1Oviposition 1Ocoxin 1Mass Screening 1Levoleucovorin 1Drainage 1Cyclophosphamide 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Intestinal Neoplasms × Levoleucovorin × Clear all
NCT01681472 2020-09-25

PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer

Isofol Medical AB

Phase 1/2 Completed
32 enrolled 52 charts
Gastrointestinal

Colonic Neoplasms, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡